{"DataElement":{"publicId":"3859382","version":"2","preferredName":"Non-Target Lesion Response RECIST Type","preferredDefinition":"Text to represent disease response in a non-targeted lesion, using RECIST response criteria.","longName":"NON_TGT_LES_RESP_TP","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2188868","version":"1","preferredName":"Non-Target Lesion Response","preferredDefinition":"Information relating to non-target lesion response.","longName":"NTRGET_LES_RESP","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206599","version":"1","preferredName":"Non-Target Lesion","preferredDefinition":"Other than the one for which something is done.:(LEE-zhun) An area of abnormal tissue change.","longName":"C25592:C3824","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Target","conceptCode":"C25592","definition":"Other than the one for which something is done.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FBB9-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177336","version":"1","preferredName":"Response","preferredDefinition":"Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.","longName":"Response","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-528C-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Denise Warzel updated Definition by seraching NCI Thesaurus in Admin tool.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"irRECIST: Immune-related Response Evaluation Criteria in Solid Tumours (RECIST)-2013","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E49C180D-8D36-0916-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"SOKKERL","dateModified":"2017-10-19","changeDescription":"8/30/17 tt transferred context, added registration status and CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3859323","version":"1.1","preferredName":"RECIST Non-Target Lesion Type","preferredDefinition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)_The identification of a lesion that is present at baseline, is measurable and is the primary target of the therapeutic intervention._The identification of a lesion that is not considered a target lesion but may be affected by the therapeutic intervention._Something distinguishable as an identifiable class based on common qualities.","longName":"3859323v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"PD","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"3284666","version":"1","preferredName":"Progressive Disease","longName":"3284666v1.00","preferredDefinition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD9FC7D6-531D-BE97-E040-BB89AD437875","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-23","modifiedBy":"MMADDINENI","dateModified":"2024-02-22","changeDescription":null,"administrativeNotes":"2023.5.17 Alt VM added per ticket request CADSR0002435. ak \r\n2023.3.15 Per LS at COG Protocol defined progressive disease (should have been added as a VM Alt Name for PV 3284666). ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"58007ED1-2112-70C3-E053-F662850A7199","beginDate":"2017-08-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-30","modifiedBy":"ONEDATA","dateModified":"2017-08-30","deletedIndicator":"No"},{"value":"Non-CR/non-PD","valueDescription":"Non Complete Response/Non Progressive Disease","ValueMeaning":{"publicId":"5946383","version":"1","preferredName":"Non Complete Response/Non Progressive Disease","longName":"5946383v1.00","preferredDefinition":"Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non Complete Response/Non Progressive Disease","conceptCode":"C96700","definition":"Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58007ED1-215D-70C3-E053-F662850A7199","latestVersionIndicator":"Yes","beginDate":"2017-08-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-30","modifiedBy":"MMADDINENI","dateModified":"2022-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"58007ED1-2176-70C3-E053-F662850A7199","beginDate":"2017-08-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-30","modifiedBy":"ONEDATA","dateModified":"2017-08-30","deletedIndicator":"No"},{"value":"CR","valueDescription":"Complete Remission","ValueMeaning":{"publicId":"3951936","version":"1","preferredName":"Complete Remission","longName":"3951936v1.00","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB155E17-C5DA-CEC3-E040-BB89AD4342C2","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-13","modifiedBy":"SOKKERL","dateModified":"2023-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"58007ED1-2180-70C3-E053-F662850A7199","beginDate":"2017-08-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-30","modifiedBy":"ONEDATA","dateModified":"2017-08-30","deletedIndicator":"No"},{"value":"NE","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3855538","version":"1","preferredName":"Unevaluable","longName":"3855538","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3F3FD8B-328D-C859-E040-BB89AD43580F","latestVersionIndicator":"Yes","beginDate":"2013-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68559546-E988-71FA-E053-F662850A31EE","beginDate":"2018-03-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"ONEDATA","dateModified":"2018-03-26","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not Done","ValueMeaning":{"publicId":"2568055","version":"1","preferredName":"Not Done","longName":"2568055","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6E4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-12","modifiedBy":"REEVESD","dateModified":"2014-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68559546-E992-71FA-E053-F662850A31EE","beginDate":"2018-03-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"ONEDATA","dateModified":"2018-03-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3859322","version":"1","preferredName":"Response Evaluation Criteria in Solid Tumors Non-Target Lesion Identification Type","preferredDefinition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com):The identification of a lesion that is not considered a target lesion but may be affected by the therapeutic intervention.:Something distinguishable as an identifiable class based on common qualities.","longName":"C49164:C94521:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response Evaluation Criteria in Solid Tumors","conceptCode":"C49164","definition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Non-Target Lesion Identification","conceptCode":"C94521","definition":"The identification of a lesion that is not considered a target lesion but may be affected by the therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E461EC27-25B5-B912-E040-BB89AD43049F","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"ONEDATA","dateModified":"2013-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RECISTv1.1:Response Evaluation Criteria in Solid Tumors v1.1","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"58001BA9-C662-28BB-E053-F662850A710E","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-30","modifiedBy":"MAESKEB","dateModified":"2020-06-24","changeDescription":"10/23/18 jk chg reg status to Standard for RECIST defined PV list; do not add PVs without checking latest version of guideline.  3/26/18 jk \"Not done\" and \"NE\" values added per 2017 iRECIST documentation, Round 5 comments and focus group activities. 8/30/17 tt versioned for changes to PVs per RECIST 1.1, changed max length, added reg status, CSI per Round 5 finalization task.  6/19/16 released. jk 8/20/13 created for RECIST CRF module based on RECISTv1.1 value definitions.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3794651","version":"1","longName":"RECIST CRF","context":"NCIP"},{"publicId":"3943912","version":"1","longName":"All Mandatory CRF CDEs","context":"NCIP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"5635298","version":"1","longName":"All Mandatory CRF CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635299","version":"1","longName":"Mandatory CRF CDEs","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6006643","version":"1","longName":"RECISTv1.1","context":"NCI Standards"},{"publicId":"5635324","version":"1","longName":"RECIST","context":"NCI Standards"}]}],"AlternateNames":[{"name":"NTGT_RESP","type":"Synonym","context":"NCIP"},{"name":"NCI Standards","type":"USED_BY","context":"NCI Standards"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Prior Question","type":"Alternate Question Text","description":"Non-target lesion ","url":null,"context":"NCIP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Nontarget lesion response","url":null,"context":"NCIP"},{"name":"Evaluation of Non-Target Lesions Based on RECIST Criteria","type":"Alternate Question Text","description":"Evaluation of Non-Target Lesions Based on RECIST Criteria","url":null,"context":"NCIP"},{"name":"Non-target lesion response","type":"Preferred Question Text","description":"Non-target lesion response","url":null,"context":"NCI Standards"},{"name":"RECIST","type":"Alternate Question Text","description":"Non-target lesion response","url":null,"context":"NCI Standards"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Non-Target Lesions Response:","url":null,"context":"COG"}],"origin":"RECISTv1.1:Response Evaluation Criteria in Solid Tumors v1.1","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"58007ED1-21A9-70C3-E053-F662850A7199","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-30","modifiedBy":"GALITG","dateModified":"2020-06-16","changeDescription":"8/30/17 tt versioned for change to VD, transferred context, changed reg status per Round 5 finalization task.6/19/16 released. jk 11/20/13 changed origin to RECISTv1.1. jc  8/20/13 created for RECIST CRF module; values based on definitions in RECISTv1.1 guideline. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}